Gain Therapeutics, Inc. earnings per share and revenue

GANX earnings per share for the last quarter are -0.17 USD whereas the estimation was -0.21 USD which accounts for 17.96% surprise. Company revenue for the same period amounts to 0.00 USD despite the estimated figure of 10.00 k USD. Estimated earnings per share for the next quarter are -0.17 USD, and revenue is expected to reach 0.00 USD. Also watch annual changes over time to get a bigger picture of GANX earnings per share and revenue dynamics.